Bruce & Co., Inc.
- SEC CIK
- 0001358331
- Latest filing
- Aug 14, 2026
Holdings in Q1 2025
Holdings as of Mar 31, 2025, filed May 14, 2025. Long positions only; changes compare share counts with Q4 2024.
- Positions
- 42
- +1 vs. Q4 2024
- Portfolio value
- $311.8M
- +$403.0K (+0.1%) vs. Q4 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| UHAL.BU-Haul Holding Co | COM SER N | 452,000 | $26.7M | 8.6% | −15,000−3.2% | Reduced | History |
| ABBVAbbVie Inc. | Stock | 127,500 | $26.7M | 8.6% | −10,000−7.3% | Reduced | History |
| ALLAllstate Corp | Stock | 125,500 | $26.0M | 8.3% | −5,000−3.8% | Reduced | History |
| FPL Group Inc302571104 | COM | 315,000 | $22.3M | 7.2% | 00.0% | Unchanged | – |
| DUKDuke Energy CORP | Stock | 175,816 | $21.4M | 6.9% | −20,000−10.2% | Reduced | History |
| TAT&T Inc. | Stock | 673,000 | $19.0M | 6.1% | −100,000−12.9% | Reduced | History |
| AERAerCap Holdings N.V. | SHS | 183,500 | $18.7M | 6.0% | +33,500+22.3% | Added | History |
| MRKMerck & Co., Inc. | COM | 202,800 | $18.2M | 5.8% | −10,000−4.7% | Reduced | History |
| ABTAbbott Laboratories | Stock | 133,800 | $17.7M | 5.7% | −14,500−9.8% | Reduced | History |
| CMSCMS Energy Corp | COM | 226,000 | $17.0M | 5.4% | −60,000−21.0% | Reduced | History |
| XELXcel Energy Inc | Stock | 194,500 | $13.8M | 4.4% | 00.0% | Unchanged | History |
| IIINInsteel Industries Inc | COM | 343,423 | $9.03M | 2.9% | 00.0% | Unchanged | History |
| AAPLApple Inc. | Stock | 38,900 | $8.64M | 2.8% | 00.0% | Unchanged | History |
| AVAAvista Corp | COM | 201,500 | $8.44M | 2.7% | 00.0% | Unchanged | History |
| PFEPfizer Inc | Stock | 271,900 | $6.89M | 2.2% | 00.0% | Unchanged | History |
| BGBunge Global SA | COM SHS | 80,000 | $6.11M | 2.0% | 00.0% | Unchanged | History |
| UHALU-Haul Holding Co | COM | 73,900 | $4.83M | 1.5% | 00.0% | Unchanged | History |
| NEMNEWMONT Corp | Stock | 100,000 | $4.83M | 1.5% | 00.0% | Unchanged | History |
| ADMArcher-Daniels-Midland Co | Stock | 100,000 | $4.80M | 1.5% | 00.0% | Unchanged | History |
| DARDarling Ingredients Inc. | COM | 141,000 | $4.40M | 1.4% | 00.0% | Unchanged | History |
| RLIRli Corp | COM | 40,800 | $3.28M | 1.1% | 00.0% | UnchangedConverted for a 2-for-1 split | History |
| VICRVicor Corp | COM | 70,000 | $3.27M | 1.1% | 00.0% | Unchanged | History |
| CCChemours Co | Stock | 200,000 | $2.71M | 0.9% | +200,000 | New | History |
| SUPNSupernus Pharmaceuticals, Inc. | COM | 82,105 | $2.69M | 0.9% | 00.0% | Unchanged | History |
| LLYEli Lilly & Co | Stock | 2,000 | $1.65M | 0.5% | 00.0% | Unchanged | History |
| Accelerate Diagnostic00430HAC6 | Cv 5.0% | – | $1.32M | 0.4% | – | – | – |
| SIRISirius XM Holdings Inc. | COM | 55,784 | $1.26M | 0.4% | 00.0% | Unchanged | History |
| Bausch Health91911K102 | Common | 171,000 | $1.11M | 0.4% | 00.0% | Unchanged | – |
| FOCLEdap TMS SA | SPONSORED ADR | 553,652 | $1.09M | 0.3% | 00.0% | Unchanged | History |
| VGVenture Global, Inc. | COM CL A | 100,000 | $1.03M | 0.3% | +100,000 | New | History |
| MNKDMannkind Corp | COM NEW | 195,073 | $981.2K | 0.3% | 00.0% | Unchanged | History |
| KODKodiak Sciences Inc. | COM | 323,000 | $907.6K | 0.3% | 00.0% | Unchanged | History |
| ASHAshland Inc. | COM | 15,000 | $889.4K | 0.3% | 00.0% | Unchanged | History |
| PSNLPersonalis, Inc. | COM | 253,000 | $888.0K | 0.3% | 00.0% | Unchanged | History |
| LVTXLAVA Therapeutics NV | SHS | 521,874 | $662.8K | 0.2% | −250,000−32.4% | Reduced | History |
| VTRSViatris Inc | Stock | 58,279 | $507.6K | 0.2% | 00.0% | Unchanged | History |
| OGNOrganon & Co. | Stock | 31,200 | $464.6K | 0.1% | 00.0% | Unchanged | History |
| FATEFate Therapeutics Inc | COM | 550,000 | $434.5K | 0.1% | +200,000+57.1% | Added | History |
| WECWec Energy Group, Inc. | Stock | 3,945 | $371.0K | 0.1% | 00.0% | Unchanged | History |
| MASS908 Devices Inc. | COM | 68,286 | $305.9K | 0.1% | 00.0% | Unchanged | History |
| CRBUCaribou Biosciences, Inc. | COM | 250,000 | $227.5K | 0.1% | 00.0% | Unchanged | History |
| IGMSIGM Biosciences, Inc. | COM | 100,000 | $115.0K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q4 2024 (1)
Positions held at the end of Q4 2024 that are gone from this filing.
| Security | Class | Shares in Q4 2024 | Value in Q4 2024 | % of portfolio in Q4 2024 | History |
|---|---|---|---|---|---|
| Acorda Theraputics00484MAB2 | Cv 6.0% | – | $200.0K | 0.1% | – |